Compare Alcon AG (ALC) vs Nvidia Corp (NVDA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Nvidia Corp — how do they compare? Alcon AG trades at $66.96 (market cap $32.69B), while Nvidia Corp trades at $199.5 (market cap $4.77T). The key difference: Nvidia Corp is far larger — about 145.9× Alcon AG's market cap, and Alcon AG pays the higher dividend (0.54%). Which is the better fit depends on your goals.
| ALC | NVDA | |
|---|---|---|
Market Cap | $32.69B | $4.77T |
Sector | Health | Technology |
52-Week High | $92.22 | $235.75 |
52-Week Low | $62.02 | $160.00 |
Enterprise Value | $36.28B | $4.70T |
Dividend Yield | 0.54% | 0.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
NVIDIA (NVDA) trades at $197.62, up 1.06% on the day, with technical indicators showing a bearish bias despite recent earnings beats. The company demonstrates exceptional fundamental strength with revenue surging to $130.5B in 2025 and net profit margins expanding to 55.84%. Analyst consensus remains strongly bullish with a $324.95 price target, representing significant upside potential from current levels.
NVIDIA's outlook is supported by dominant AI chip positioning and accelerating revenue growth, though risks include increased competition, peak AI infrastructure spending concerns, and rich valuations. The stock presents a compelling growth opportunity for investors comfortable with technology sector volatility and premium valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
